Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2022
This report studies the global Next Generation Diabetes Therapy and Drug Delivery market, analyzes and researches the Next Generation Diabetes Therapy and Drug Delivery development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Abbott Laboratories
- Medtronic
- Sanofi
- Novo Nordisk
- MannKind Corporation
- Enteris BioPharma
- Dexcom
- Senseonics Holding
- Medtech
- Johnson & Johnson
- Synertech
- Zosano Pharma Corp
- Relmada Therapeutics
- Eli Lilly and Company
- Transdermal Specialties
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Inhalable Insulin
- Oral Insulin
- Insulin Patches
- CGM Systems
- Artificial Pancreas
- Diagnostic/Clinics
- ICUs
- Home Healthcare
Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY
1.1 Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.1.1 Next Generation Diabetes Therapy and Drug Delivery Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Next Generation Diabetes Therapy and Drug Delivery Market by Type
1.3.1 Inhalable Insulin
1.3.2 Oral Insulin
1.3.3 Insulin Patches
1.3.4 CGM Systems
1.3.5 Artificial Pancreas
1.4 Next Generation Diabetes Therapy and Drug Delivery Market by End Users/Application
1.4.1 Diagnostic/Clinics
1.4.2 ICUs
1.4.3 Home Healthcare
2 GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY COMPETITION ANALYSIS BY PLAYERS
2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Medtronic
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Sanofi
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Novo Nordisk
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 MannKind Corporation
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Enteris BioPharma
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Dexcom
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Senseonics Holding
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Medtech
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Johnson & Johnson
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Synertech
3.12 Zosano Pharma Corp
3.13 Relmada Therapeutics
3.14 Eli Lilly and Company
3.15 Transdermal Specialties
4 GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2012-2017)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2012-2017)
4.3 Potential Application of Next Generation Diabetes Therapy and Drug Delivery in Future
4.4 Top Consumer/End Users of Next Generation Diabetes Therapy and Drug Delivery
5 UNITED STATES NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
5.2 United States Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
6 EU NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
6.2 EU Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
7 JAPAN NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
7.2 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
8 CHINA NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
8.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
9 INDIA NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
9.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
9.2 India Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
10.2 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Regions (2017-2022)
11.1.1 United States Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.2 EU Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.3 Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.4 China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.5 India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Type (2017-2022)
11.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
12 NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET DYNAMICS
12.1 Next Generation Diabetes Therapy and Drug Delivery Market Opportunities
12.2 Next Generation Diabetes Therapy and Drug Delivery Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Next Generation Diabetes Therapy and Drug Delivery Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Next Generation Diabetes Therapy and Drug Delivery Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY
1.1 Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.1.1 Next Generation Diabetes Therapy and Drug Delivery Product Scope
1.1.2 Market Status and Outlook
1.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Next Generation Diabetes Therapy and Drug Delivery Market by Type
1.3.1 Inhalable Insulin
1.3.2 Oral Insulin
1.3.3 Insulin Patches
1.3.4 CGM Systems
1.3.5 Artificial Pancreas
1.4 Next Generation Diabetes Therapy and Drug Delivery Market by End Users/Application
1.4.1 Diagnostic/Clinics
1.4.2 ICUs
1.4.3 Home Healthcare
2 GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY COMPETITION ANALYSIS BY PLAYERS
2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Abbott Laboratories
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Medtronic
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Sanofi
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Novo Nordisk
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 MannKind Corporation
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Enteris BioPharma
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Dexcom
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Senseonics Holding
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Medtech
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Johnson & Johnson
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Next Generation Diabetes Therapy and Drug Delivery Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Synertech
3.12 Zosano Pharma Corp
3.13 Relmada Therapeutics
3.14 Eli Lilly and Company
3.15 Transdermal Specialties
4 GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2012-2017)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2012-2017)
4.3 Potential Application of Next Generation Diabetes Therapy and Drug Delivery in Future
4.4 Top Consumer/End Users of Next Generation Diabetes Therapy and Drug Delivery
5 UNITED STATES NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
5.2 United States Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
6 EU NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
6.2 EU Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
7 JAPAN NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
7.2 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
8 CHINA NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
8.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
9 INDIA NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
9.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
9.2 India Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2012-2017)
10.2 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Regions (2017-2022)
11.1.1 United States Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.2 EU Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.3 Japan Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.4 China Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.5 India Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2017-2022)
11.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Value) by Type (2017-2022)
11.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
12 NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET DYNAMICS
12.1 Next Generation Diabetes Therapy and Drug Delivery Market Opportunities
12.2 Next Generation Diabetes Therapy and Drug Delivery Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Next Generation Diabetes Therapy and Drug Delivery Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Next Generation Diabetes Therapy and Drug Delivery Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Next Generation Diabetes Therapy and Drug Delivery Product Scope
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) (2012-2017)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions in 2016
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type in 2016
Figure Inhalable Insulin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Oral Insulin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Insulin Patches Market Size (Million USD) and Growth Rate (2012-2017)
Figure CGM Systems Market Size (Million USD) and Growth Rate (2012-2017)
Figure Artificial Pancreas Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application in 2016
Table Key Downstream Customer in Diagnostic/Clinics
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate in Diagnostic/Clinics (2012-2017)
Table Key Downstream Customer in ICUs
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate in ICUs (2012-2017)
Table Key Downstream Customer in Home Healthcare
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate in Home Healthcare (2012-2017)
Table Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2016 and 2017)
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Table Abbott Laboratories Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Medtronic Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Medtronic (2012-2017)
Figure Medtronic Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Novo Nordisk Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Novo Nordisk (2012-2017)
Figure Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table MannKind Corporation Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of MannKind Corporation (2012-2017)
Figure MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Enteris BioPharma Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Enteris BioPharma (2012-2017)
Figure Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Dexcom Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Dexcom (2012-2017)
Figure Dexcom Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Senseonics Holding Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Senseonics Holding (2012-2017)
Figure Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Medtech Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Medtech (2012-2017)
Figure Medtech Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Synertech Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Synertech (2012-2017)
Figure Synertech Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Zosano Pharma Corp Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Zosano Pharma Corp (2012-2017)
Figure Zosano Pharma Corp Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Relmada Therapeutics Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Relmada Therapeutics (2012-2017)
Figure Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Eli Lilly and Company Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Eli Lilly and Company (2012-2017)
Figure Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Transdermal Specialties Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Transdermal Specialties (2012-2017)
Figure Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Type (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2012
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2013
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2014
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2015
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2016
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2017
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2012
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2013
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2014
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2015
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2016
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Next Generation Diabetes Therapy and Drug Delivery
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Regions (2017-2022)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Regions (2017-2022)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Regions in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Regions in 2022
Figure United States Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Type (2017-2022)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2022
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application (2017-2022)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2022
Figure Next Generation Diabetes Therapy and Drug Delivery Product Scope
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) (2012-2017)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions in 2016
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type in 2016
Figure Inhalable Insulin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Oral Insulin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Insulin Patches Market Size (Million USD) and Growth Rate (2012-2017)
Figure CGM Systems Market Size (Million USD) and Growth Rate (2012-2017)
Figure Artificial Pancreas Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application in 2016
Table Key Downstream Customer in Diagnostic/Clinics
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate in Diagnostic/Clinics (2012-2017)
Table Key Downstream Customer in ICUs
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate in ICUs (2012-2017)
Table Key Downstream Customer in Home Healthcare
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate in Home Healthcare (2012-2017)
Table Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2016 and 2017)
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Table Abbott Laboratories Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Medtronic Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Medtronic (2012-2017)
Figure Medtronic Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Novo Nordisk Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Novo Nordisk (2012-2017)
Figure Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table MannKind Corporation Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of MannKind Corporation (2012-2017)
Figure MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Enteris BioPharma Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Enteris BioPharma (2012-2017)
Figure Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Dexcom Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Dexcom (2012-2017)
Figure Dexcom Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Senseonics Holding Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Senseonics Holding (2012-2017)
Figure Senseonics Holding Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Medtech Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Medtech (2012-2017)
Figure Medtech Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Synertech Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Synertech (2012-2017)
Figure Synertech Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Zosano Pharma Corp Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Zosano Pharma Corp (2012-2017)
Figure Zosano Pharma Corp Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Relmada Therapeutics Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Relmada Therapeutics (2012-2017)
Figure Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Eli Lilly and Company Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Eli Lilly and Company (2012-2017)
Figure Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Transdermal Specialties Basic Information List
Table Next Generation Diabetes Therapy and Drug Delivery Business Revenue (Million USD) of Transdermal Specialties (2012-2017)
Figure Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Business Revenue Market Share in 2016
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Type (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2012
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2013
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2014
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2015
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2016
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2017
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application (2012-2017)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2012
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2013
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2014
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2015
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2016
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Next Generation Diabetes Therapy and Drug Delivery
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure United States Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure EU Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure China Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure India Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2016
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Players in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Regions (2017-2022)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Regions (2017-2022)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Regions in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Regions in 2022
Figure United States Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Type (2017-2022)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type in 2022
Table Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application (2017-2022)
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2017
Figure Global Next Generation Diabetes Therapy and Drug Delivery Market Size (Million USD) by Application in 2022
